Melanotan I
Melanotan I (afamelanotide) is a synthetic analog of α-melanocyte stimulating hormone that selectively targets MC1 receptors to stimulate melanin production.
Also known as: Melanocortin Receptor Agonist, Afamelanotide
Overview
Melanotan I (afamelanotide) is a synthetic analog of α-melanocyte stimulating hormone that selectively targets MC1 receptors to stimulate melanin production. While an FDA-approved implant version (SCENESSE®) exists for rare medical conditions, research-grade injectable Melanotan I is studied for its photoprotective and tanning effects through regular subcutaneous administration.
Key Benefits
- Enhanced Tanning Response
- Photoprotection
- Even Pigmentation
Research-grade injectable Melanotan I provides precise dosing control and rapid onset of tanning effects. Unlike the FDA-approved SCENESSE® implant, injectable form allows flexible dosing and can be administered at home. Produces visible tanning within 1-2 weeks with proper UV exposure.
Mechanism of Action
Subcutaneous injection delivers Melanotan I directly into systemic circulation with 100% bioavailability. 30-minute half-life requires multiple daily injections for sustained MC1R activation and melanin production.
Research Protocols Injectable
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Initial Tanning (Light Skin) | 0.25mg | 2x daily | Subcutaneous |
| Maintenance Tanning | 0.5mg | 1x daily | Subcutaneous |
| Enhanced Pigmentation | 0.5mg | 2x daily | Subcutaneous |
| Photoprotection Only | 0.25mg | 1x daily | Subcutaneous |
Research protocols from published literature — not dosing recommendations.
Peptide Interactions
- Melanotan II — Compatible: Both target melanocortin receptors but Melanotan I has better safety profile and selectivity for MC1R. Should not be combined due to overlapping mechanisms and additive effects.
- UV Exposure — Synergistic: Melanotan I enhances tanning response to UV exposure, allowing deeper pigmentation with less sun exposure. Reduces required UV dose for tanning by approximately 50%.
- Beta-Carotene — Compatible: Natural carotenoid provides additional photoprotection. No known interactions with Melanotan I. Can be used together for enhanced skin protection.
- Tretinoin/Retinoids — Monitor Combination: Retinoids increase skin photosensitivity while Melanotan I provides photoprotection. Monitor for skin reactions and adjust UV exposure accordingly.
- Photosensitizing Medications — Use Caution: Antibiotics, diuretics, and other photosensitizing drugs may increase UV sensitivity. Enhanced monitoring recommended when combining with Melanotan I.
- Self-Tanning Products — Compatible: Topical self-tanners work through different mechanisms (DHA) and can be used alongside Melanotan I for enhanced cosmetic appearance.
Peptide Instructions Injectable
Supplies:
- Bacteriostatic water (BAC water)
- Insulin syringes (29-31 gauge)
- Alcohol swabs
- Melanotan I lyophilized powder vial
How to Reconstitute Injectable
- 1Allow vial to reach room temperature (15-20 minutes)
- 2Clean vial top with alcohol swab and allow to dry
- 3Calculate required bacteriostatic water volume using the calculator below
- 4Draw calculated volume of bacteriostatic water into syringe
- 5Inject water slowly down the inside wall of the vial (never directly onto powder)
- 6Gently swirl until powder completely dissolves (never shake)
- 7Solution should be clear - discard if cloudy or contains particles
- 8Store reconstituted solution in refrigerator at 2-8°C
What to Expect Injectable
Days 1-3: Possible mild nausea, facial flushing, reduced appetite. Days 3-7: Initial skin darkening, increased pigmentation of moles and freckles. Week 1-2: Noticeable tanning with minimal UV exposure, enhanced tanning response. Week 2-4: Peak tanning effects, maintained pigmentation with reduced injection frequency.
Side Effects & Safety
Research peptide - not approved for human consumption, sold for research purposes only. Start with lower doses to assess individual tolerance and response. Monitor moles and skin changes - perform regular self-examinations. Use proper sterile injection technique to prevent infections. Maintain UV protection despite enhanced tanning - still risk of overexposure.
Research peptide - not approved for human consumption, sold for research purposes only. Start with lower doses to assess individual tolerance and response. Monitor moles and skin changes - perform regular self-examinations. Use proper sterile injection technique to prevent infections. Maintain UV protection despite enhanced tanning - still risk of overexposure.
Community Insights
Melanotan I should be stored at Powder: room temperature or refrigerated; Reconstituted: 2-8°C for up to 4 weeks.
References
- Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization
- Melanotan I reduces the incidence of acute and chronic UV-induced skin damage
- Safety Profile Assessment
- Evaluation of melanotan-I, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
- MT-I Photoprotection Study
- Tanning Efficacy Comparison
- The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation
- Pharmacokinetics of [Nle4,D-Phe7]-alpha-MSH in rats and humans
- Melanocortin Receptor Binding Study
- Pharmacokinetics of Injectable MT-I
- Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin
Research reference only. Not medical advice.